drugset / Trial / NCT00705159

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

NCT00705159

Phase 4 Completed 137 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the safety and effectiveness of Zylet in comparison with Lotemax, Tobramycin and the vehicle of Zylet for the treatment of blepharoconjunctivitis in pediatric subjects.

Timeline

Start
2008-06
Primary completion
2010-03
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loteprednol Etabonate Other / unclassified Topical
Comparator Tobramycin Small molecule Topical

Indications